Skip to main content
Livermore
Livermore
ZHEN

Arrowhead Pharmaceuticals, Inc.

ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000879407

In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Arrowhead Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ARWR: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders2642281+19
Shares105.3M30.4K105.8M+531.3K (+0.5%)
Value$1.34B$387.0K$1.67B+$329.9M (+24.6%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (57)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ARWR in Q2 2025
InstitutionSharesValue% of portfolio
Baker Bros. Advisors LP939,174$14.8M0.14%
Trexquant Investment LP503,654$7.96M0.09%
Dimensional Fund Advisors LP366,711$5.79M0.00%
PDT Partners, LLC152,988$2.42M0.14%
Neo Ivy Capital Management138,081$2.18M0.70%
Algert Global LLC102,490$1.62M0.03%
Franklin Resources Inc81,226$1.28M0.00%
Alps Advisors Inc74,497$1.18M0.01%
Arrowstreet Capital, Limited Partnership64,200$1.01M0.00%
Boothbay Fund Management, LLC61,947$978.8K0.03%
Bayforest Capital Ltd59,403$938.6K0.41%
Los Angeles Capital Management LLC57,948$915.6K0.00%
Winton Group Ltd41,778$660.1K0.03%
EP Wealth Advisors, LLC38,524$608.7K0.00%
Y-Intercept (Hong Kong) Ltd31,105$491.5K0.01%
Graham Capital Management, L.P.24,063$380.2K0.01%
Sherbrooke Park Advisers LLC22,712$358.9K0.16%
Group One Trading, L.P.19,354$305.8K0.01%
Teza Capital Management LLC18,961$299.6K0.22%
Gotham Asset Management, LLC18,863$298.0K0.00%
Pathstone Holdings, LLC17,635$278.6K0.00%
Ieq Capital, LLC17,189$271.6K0.00%
CI Private Wealth, LLC17,056$269.5K0.00%
Cantor Fitzgerald, L. P.17,000$268.6K0.01%
Wealth Enhancement Advisory Services, LLC15,580$261.6K0.00%
Virtus ETF Advisers LLC15,644$247.2K0.15%
Moody Lynn & Lieberson, LLC13,500$213.3K0.01%
Advantage Alpha Capital Partners LP12,938$204.4K0.06%
Neuberger Berman Group LLC12,652$199.9K0.00%
Scotia Capital Inc.11,795$186.4K0.00%
Arrowroot Family Office, LLC11,300$178.5K0.08%
Scientech Research LLC10,959$173.2K0.04%
Bryce Point Capital, LLC10,409$164.5K0.14%
Wexford Capital LP9,229$145.8K0.04%
State of Wyoming9,015$142.4K0.02%
Lazard Asset Management LLC5,771$91.0K0.00%
Leonteq Securities AG1,630$25.8K0.00%
Acadian Asset Management LLC1,542$24.0K0.00%
Total Investment Management Inc1,244$19.7K0.00%
STRS Ohio1,200$19.0K0.00%
Mount Yale Investment Advisors, LLC1,200$19.0K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1,048$17.0K0.00%
Global Retirement Partners, LLC227$3.59K0.00%
Private Wealth Management Group, LLC206$3.25K0.00%
Atlantic Trust, LLC152$2.40K0.00%
Activest Wealth Management93$1.47K0.00%
Versant Capital Management, Inc87$1.38K0.00%
Annis Gardner Whiting Capital Advisors, LLC80$1.26K0.00%
Essential Partners LLC73$1.15K0.00%
Twin Peaks Wealth Advisors, LLC49$8720.00%
Bare Financial Services, Inc48$7580.00%
Koesten, Hirschmann & Crabtree, INC.47$7380.00%
Fortitude Family Office, LLC38$6000.00%
WealthTrak Capital Management LLC30$4740.00%
Huntington National Bank18$2840.00%
National Bank of Canada10$1580.00%
Larson Financial Group LLC9$1420.00%

Sold out (38)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of ARWR in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Aquilo Capital Management, LLC550,130$7.01M
Squarepoint Ops LLC240,175$3.06M
Schroder Investment Management Group165,122$2.28M
Integral Health Asset Management, LLC175,000$2.23M
Capital International Investors126,230$1.61M
State of New Jersey Common Pension Fund D102,572$1.31M
Balyasny Asset Management LLC99,723$1.27M
Walleye Capital LLC93,041$1.19M
Jump Financial, LLC88,204$1.12M
HRT Financial LP73,577$937.0K
Gsa Capital Partners LLP71,685$913.0K
Magnetar Financial LLC70,375$896.6K
CenterBook Partners LP66,913$852.5K
Tudor Investment Corp Et Al65,708$837.1K
Corebridge Financial, Inc.62,556$797.0K
TD Asset Management Inc56,606$721.2K
Fox Run Management, L.L.C.55,404$705.8K
Quadrant Capital Group LLC19,169$244.2K
Bridgefront Capital, LLC15,324$195.2K
Universal- Beteiligungs- und Servicegesellschaft mbH13,622$173.5K
HSBC Holdings PLC13,850$172.8K
Walleye Trading LLC13,158$167.6K
Bayesian Capital Management, LP13,000$165.6K
Gratus Wealth Advisors, LLC12,250$156.1K
XTX Topco Ltd10,421$132.8K
Aster Capital Management (DIFC) Ltd3,190$60.3K
Coldstream Capital Management Inc2,380$30.3K
Caitong International Asset Management Co., Ltd1,300$16.6K
Picton Mahoney Asset Management511$7.00K
Boston Private Wealth LLC473$6.03K
High Note Wealth, LLC209$2.66K
Stonebridge Financial Group, LLC100$1.27K
UMA Financial Services, Inc.68$867
Stephens Consulting, LLC50$637
JFS Wealth Advisors, LLC39$497
Ronald Blue Trust, Inc.27$344
Bokf, NA22$280
AdvisorNet Financial, Inc12$153

Not filed for Q2 2025 yet (2)

Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARWR in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Buffington Mohr McNeal30,000$382.2K
Lindbrook Capital, LLC377$4.80K